CARbon Impact of aNesthesic Gas

NCT ID: NCT04163848

Last Updated: 2021-01-27

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 58 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2019-09-25
• Study Completion Date: 2020-01-23

Brief Summary

Assessing the impact of anesthesia practice on global warming and carbon footprint becomes part of the standard of care and is growing concern within the anesthesia community. Global Warming Potential (GWP) is a measure of how much a given mass of greenhouse gas contributes to global warming over a specified time period. Inhaled anesthetics have various GWP20: 349 for sevoflurane and 3714 for desflurane. However, GWP20 and CDE20 alone are not sufficient to evaluate the environmental impact of anesthetic gases. Other parameters must be included in the analysis: fresh gas flow (FGF), carrier gas (air, O2, N2O) and potency of the anesthetic gas. Unfortunately, the majority of trials did not fully consider the FGF reduction and the fact that desflurane can be administered with new closed or very low-flow anesthesia circuits as opposed as the recommended 2L/min that must be used for sevoflurane according to its monography in Canada. Most of the calculations were made on a purely theoretical approach that could be different from actual measurements based on a strictly monitored anesthesia practice. When continuous and accurate gas monitoring and analysis is used as recommended nowadays, the use of closed or semi-closed-circuit anesthesia with very low FGF might allow for a reduction of more than 80% of the anesthetic gas administration and its consequent pollution. By properly monitoring the anesthesia depth and analgesia adequacy, the investigators can reduce the gas consumption. The proposed study will aim at determining whether with the help of high-quality monitoring (BIS and NOL) and high-end ventilators that allow minimal fresh gas flow, the use of desflurane remains more polluting than sevoflurane.

Conditions

Gas; Inhalation; Anesthesia

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: PROSPECTIVE

Study Groups

Desflurane

desflurane administration based on a BIS index kept between 40-60 and with use of the semi-closed circuit of the Draeger A500 ventilator and its econometer for an optimized fresh gas flow as low as the O2 consumption allows

Pollution

Intervention Type: OTHER

CO2 equivalent productions related to anesthetic gases use during general anesthesia for laparoscopic surgery

Sevoflurane

sevoflurane administration based on a BIS kept between 40-60 and with use of the semi-closed circuit of the Draeger A500 ventilator with a fixed fresh gas flow of 2L/min as requested in the gas monography

Pollution

Intervention Type: OTHER

CO2 equivalent productions related to anesthetic gases use during general anesthesia for laparoscopic surgery

Interventions

Pollution

CO2 equivalent productions related to anesthetic gases use during general anesthesia for laparoscopic surgery

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• ASA 1-3 patients,
• laparoscopic general, gynecological or urologic surgery requiring general anesthesia without additional regional anesthesia technique
• fully consented,
• BMI < 40,
• age > 18yo,

Exclusion Criteria

• post-operative need for a neuraxial or regional analgesic technique
• history of active coronary artery disease
• serious cardiac arrhythmia (including atrial fibrillation)
• history of substance abuse
• chronic use of psychotropic and/or opioid drugs
• history of psychiatric diseases with the need of medication
• history of refractory PONV
• allergy or contra-indication to any drug used in the study protocol
• refusal of the patient for participation in the study

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ciusss de L'Est de l'Île de Montréal

OTHER

Sponsor Role: lead

Responsible Party

Olivier Verdonck

Assistant Professor, Deputy chief of the Department of Anesthesiology of Maisonneuve-Rosemont Hospital, University of Montreal(UDeM)

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montréal

Montreal, Quebec, Canada

Countries

Canada

Other Identifiers

2020-1971

Identifier Type: -

Identifier Source: org_study_id